1 Changlai SP, "Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer" 8 : 337-339, 2001
2 Griffioen GH, "Radical treatment of synchronous oligometastatic nonsmall cell lung carcinoma (NSCLC): patient outcomes and prognostic factors" 82 : 95-102, 2013
3 Penel N, "Pronostic factors of synchronous brain metastases from lung cancer" 33 : 143-154, 2001
4 Fischer B, "Preoperative staging of lung cancer with combined PETCT" 361 : 32-39, 2009
5 Maziak DE, "Positron emission tomography in staging early lung cancer: a randomized trial" 151 : 221-228, 2009
6 Yohena T, "Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis" 10 : 347-349, 2004
7 Sider L, "Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT" 151 : 893-895, 1988
8 van Tinteren H, "Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial" 359 : 1388-1393, 2002
9 Yokoi K, "Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI" 115 : 714-719, 1999
10 Balekian AA, "Brain imaging for staging of patients with clinical stage IA non-small cell lung cancer in the national lung screening trial: adherence with recommendations from the choosing wisely campaign" 149 : 943-950, 2016
1 Changlai SP, "Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer" 8 : 337-339, 2001
2 Griffioen GH, "Radical treatment of synchronous oligometastatic nonsmall cell lung carcinoma (NSCLC): patient outcomes and prognostic factors" 82 : 95-102, 2013
3 Penel N, "Pronostic factors of synchronous brain metastases from lung cancer" 33 : 143-154, 2001
4 Fischer B, "Preoperative staging of lung cancer with combined PETCT" 361 : 32-39, 2009
5 Maziak DE, "Positron emission tomography in staging early lung cancer: a randomized trial" 151 : 221-228, 2009
6 Yohena T, "Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis" 10 : 347-349, 2004
7 Sider L, "Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT" 151 : 893-895, 1988
8 van Tinteren H, "Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial" 359 : 1388-1393, 2002
9 Yokoi K, "Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI" 115 : 714-719, 1999
10 Balekian AA, "Brain imaging for staging of patients with clinical stage IA non-small cell lung cancer in the national lung screening trial: adherence with recommendations from the choosing wisely campaign" 149 : 943-950, 2016
11 송재욱, "Are There Any Additional Benefits to Performing Positron Emission Tomography/Computed Tomography Scans and Brain Magnetic Resonance Imaging on Patients with Ground-Glass Nodules Prior to Surgery?" 대한결핵및호흡기학회 80 (80): 368-376, 2017